Julie Randall shares about life after cancer at Providence Creating Hope Dinner. Learn more ›
When cancer hits home, expert care is close by. With a newly expanded cancer center, Providence Hood River Memorial Hospital offers expert care for patients in the Columbia Gorge. Learn more ›
Videos featuring basic information about common side effects beyond cancer treatment. Each video features patients stories and practical advice from an oncology specialist on how to cope. Learn more ›
Breakthrough treatments. Transformative care. And more of everyone and everything you love. Learn more ›
Search by keyword or filter by cancer type to learn more about the numerous clinical trials and research studies underway at Providence Cancer Institute. Learn more ›
Cancer researchers at Providence Cancer Institute study a unique approach, combining radiation and immunotherapy treatments. Learn more ›
When you first hear the words, “It’s cancer,” the road ahead may seem overwhelming. From that moment on, we surround you with a team of cancer specialists to help you through the journey.
PROVIDENCE CANCER CLINICS
SUPPORTING OUR PATIENTS
PERSONALIZED CANCER CARE
T-cell checkpoint antibodies have revolutionized immunotherapy for cancer, including renal cancer. At Providence Cancer Institute, several clinical trials of these novel approaches are now open to patients with renal...
In his lifetime and through his estate, the late Robert W. Franz gave close to $40 million to Providence Portland Medical Foundation. Providence Cancer Institute has been renamed in his honor.
Phase I studies are the foundation for advancing cancer treatment with new agents and combinations of therapies. Providence Cancer Institute is often able to offer patients first-in-human clinical trials of novel cancer...
A first-of-its-kind clinical study may offer new hope to patients battling rectal cancer.
The Phase 2 study, newly underway at Providence Cancer Institute, is led by Kristina Young, M.D., Ph.D., who was recognized in 2016...
Learn more about breast cancer screening and the importance of mammograms, featuring Dr. Anupama Acheson from Providence Cancer Institute.
Patients with hormone-receptor-positive, HER2-positive metastatic breast cancer may qualify for a newly opened clinical trial at Providence Cancer Institute. The PATINA trial expects to demonstrate that adding the...
Two new studies of investigational and FDA-approved immunotherapies for advanced melanoma are opening soon at Providence Cancer Institute.
With the release of her book Patient 71, Australia native Julie Randall has given cancer patients across the globe hope for life after cancer. Her remarkable story of overcoming stage IV metastatic melanoma was featured in...
Known as "Patient 71," persistence paid off for Australian cancer patient Julie Randall
Learn more about her story ›
She now devotes her time to sharing her inspirational story and spreading a word of hope to...
Two studies at Providence Cancer Institute are focusing on patients’ genomes to help identify the most effective targeted anti-cancer therapies.
It has been a busy and exciting start to 2017 for immunotherapy researcher Eric Tran, Ph.D., and it could make a great difference in the lives of people fighting cancer.